Biocon Limited (which holds around 78 per cent) will acquire the remaining stake in Biocon Biologics through a share swap…
With Mohandas Pai and Kiran Mazumdar-Shaw emerging as mouthpieces of the Bengaluru pothole row, both key figures shared big words…
In her recent X post of the meeting, a user said the plan should be named as “challenge plan” to…
Shaw has been vocal in her criticism of infrastructure in the capital city — highlighting issues through social media and…
Rajya Sabha MP P Chidambaram lauded Kiran Mazumdar-Shaw’s offer to fix Bengaluru while pointing out the key challenge in public…
After multiple comments, the Karnataka Deputy CM, who also happens to be Bengaluru Development and Town Planning said on Saturday…
Kiran Mazumdar-Shaw responded to her “selective outrage” charge on social media, saying that she has “vested interest in Bengaluru” as…
In a post on social media platform X, Shaw said the situation at present is “dire” due to the “failures”…
On Monday, the Chief Commissioner of Greater Bengaluru Authority (GBA) instructed officials to fasten the repair work on the Outer…
Kiran Mazumdar-Shaw has expressed concern over the sorry state of Bengaluru, adding that all it needs is political urgency, focus,…
In total, the seven women command wealth surpassing $70 billion, covering industries from steel, pharma, fintech, retail, and biotechnology.
After Mohandas Pai shared a list of “most corrupt departments” in India, Kiran Mazumdar-Shaw has strongly reacted to it, and…
The state government on Tuesday constituted the Greater Bengaluru Authority, a 75-member body tasked with coordinating across the five newly…
After BJP MP Tejasvi Surya wrote an open letter to authorities over the poor condition of roads and public infrastructure,…
“The budget has the right focus. Also, while the customs duty waiver on imported cancer drugs is a laudable move,…
Each of them has redefined what it means to leave a legacy, proving that age is not a limitation but…
Kiran Mazumdar-Shaw, Executive Chairperson – Biocon and Biocon Biologics said, “I am confident that India’s pharma sector will be recognised…
Bicara Therapeutics, a clinical-stage biopharmaceutical company, focuses on bringing transformative bifunctional therapies for patients with solid tumors.